Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings entities : Teva pharmaceutical industries ltd save search
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Published: 2024-04-09 (Crawled : 23:00) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: -0.7%
H: 0.07%
C: -0.92%
first conference teva financial results
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Published: 2024-01-02 (Crawled : 00:00) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 0.29%
H: 3.53%
C: 1.91%
conference year teva financial results
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 2.54%
H: 3.23%
C: -1.29%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
revenue teva financial results
Teva Reports Second Quarter 2023 Financial Results
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 5.55%
H: 8.46%
C: 5.71%
teva financial results
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Published: 2023-05-10 (Crawled : 13:00) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: -8.46%
H: 2.1%
C: 0.24%
teva financial results
Teva Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-08 (Crawled : 13:00) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: -4.22%
H: 0.48%
C: -4.89%
teva year financial results
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
Published: 2023-01-12 (Crawled : 23:00) - biospace.com/
TEVJF | $12.37 -24.22% 380
|
Health Technology
|
| O: 5.87%
H: 0.0%
C: 0.0%
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 0.0%
H: 2.65%
C: 1.97%
conference teva year financial results
Alvotech to Report First Six Months and Second Quarter 2022 Financial Results on August 31, 2022 and Host Business Update Conference Call at 8:00 am ET on September 1, 2022
Published: 2022-08-15 (Crawled : 09:00) - biospace.com/
ALVO | $12.69 1.52% 1.5% 370K
|
n/a
|
| O: -0.78%
H: 19.48%
C: 19.48%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.38%
H: 2.07%
C: 2.07%
conference report six update results
Teva Reports First Quarter 2022 Financial Results
Published: 2022-05-03 (Crawled : 12:20) - biospace.com/
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
results
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-09 (Crawled : 13:30) - biospace.com/
EGRX | $4.66 -10.39% -11.59% 160K
|
Health Technology
|
| O: 3.87%
H: 1.76%
C: 0.69%
financial results report results
Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
Published: 2022-02-04 (Crawled : 15:00) - biospace.com/
RARE | $42.32 -1.28% -1.3% 890K
|
Health Technology
|
| O: -2.36%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
REGN | $894.265 -0.48% -0.48% 610K
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
report results
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022
Published: 2022-01-18 (Crawled : 13:30) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: -0.22%
H: 0.55%
C: -2.09%
financial results conference results
Teva Reports Third Quarter 2021 Financial Results
Published: 2021-10-27 (Crawled : 12:00) - biospace.com/
TEVJF | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
financial results results
Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021
Published: 2021-10-01 (Crawled : 17:00) - biospace.com/
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
financial results results conference
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.